Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/132145Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Huang, David B. | - |
| dc.contributor.author | Duncan, Leonard R. | - |
| dc.contributor.author | Flamm, Robert K. | - |
| dc.contributor.author | Dryden, Matthew | - |
| dc.contributor.author | Corey, G. Ralph | - |
| dc.contributor.author | Wilcox, Mark H. | - |
| dc.contributor.author | Torres Martí, Antoni | - |
| dc.contributor.author | File, Thomas M. | - |
| dc.date.accessioned | 2019-04-12T07:57:52Z | - |
| dc.date.available | 2019-04-12T07:57:52Z | - |
| dc.date.issued | 2018-01 | - |
| dc.identifier.issn | 0732-8893 | - |
| dc.identifier.uri | http://hdl.handle.net/2445/132145 | - |
| dc.description.abstract | The in vitro antimicrobial activity of iclaprim, a novel diaminopyrimidine, against common respiratory bacteria remained unchanged in the presence of pulmonary surfactant (Survanta®) at concentrations that greatly antagonized the antimicrobial activity of daptomycin. These results indicate that iclaprim could be a potential treatment for pneumonia caused by susceptible and multidrug resistant bacteria. | - |
| dc.format.extent | 3 p. | - |
| dc.format.mimetype | application/pdf | - |
| dc.language.iso | eng | - |
| dc.publisher | Elsevier B.V. | - |
| dc.relation.isformatof | Versió postprint del document publicat a: https://doi.org/10.1016/j.diagmicrobio.2017.09.011 | - |
| dc.relation.ispartof | Diagnostic Microbiology and Infectious Disease, 2018, vol. 90, num. 1, p. 64-66 | - |
| dc.relation.uri | https://doi.org/10.1016/j.diagmicrobio.2017.09.011 | - |
| dc.rights | cc-by-nc-nd (c) Elsevier B.V., 2018 | - |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/es | - |
| dc.subject.classification | Pneumònia | - |
| dc.subject.classification | Bacteris patògens | - |
| dc.subject.classification | Efecte dels medicaments sobre els microorganismes | - |
| dc.subject.other | Pneumonia | - |
| dc.subject.other | Pathogenic bacteria | - |
| dc.subject.other | Effect of drugs on microorganisms | - |
| dc.title | The effect of pulmonary surfactant on the in vitro activity of Iclaprim against common respiratory bacterial pathogens | - |
| dc.type | info:eu-repo/semantics/article | - |
| dc.type | info:eu-repo/semantics/acceptedVersion | - |
| dc.identifier.idgrec | 675127 | - |
| dc.date.updated | 2019-04-12T07:57:52Z | - |
| dc.rights.accessRights | info:eu-repo/semantics/openAccess | - |
| Appears in Collections: | Articles publicats en revistes (Medicina) Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer) | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| 675127.pdf | 156.84 kB | Adobe PDF | View/Open |
This item is licensed under a
Creative Commons License
